Prescription drug · ANDA
busPIRone HCl (buspirone hydrochloride) NDC 72888-066
Buspirone hydrochloride 30 mg/1 · Tablet · Oral · Advagen Pharma Ltd
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 72888-066-05 | 72888006605 | 500 TABLET in 1 BOTTLE (72888-066-05)Marketed from Mar 16, 2021 | |
| 72888-066-60 | 72888006660 | 60 TABLET in 1 BOTTLE (72888-066-60)Marketed from Mar 16, 2021 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- busPIRone HCl
- Generic name (nonproprietary)
- buspirone hydrochloride
- Active ingredients
- Buspirone hydrochloride — 30 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Advagen Pharma Ltd
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 075521
- Marketing start
- Listing expires
- Identifiers
- Product ID 72888-066_47c7577d-5093-5361-e063-6294a90ae76fSPL ID 47c7577d-5093-5361-e063-6294a90ae76fSPL set ID 07a789a9-c9e8-4737-a56d-7d5405fe8100RxCUI 866018, 866083, 866090, 866094, 866111UNII 207LT9J9OCUPC 0372888064055, 0372888065052, 0372888062013, 0372888066608, 0372888064017, 0372888065014, 0372888062051, 0372888063010, 0372888066059, 0372888065601, 0372888063058
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N472888006605followed by a unit qualifier and the quantityPackage 72888-0066-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Buspirone hydrochloride tablets are indicated for the management of anxiety disorders or the short-term relief of the symptoms of anxiety. Anxiety or tension associated with the stress of everyday life usually does not require treatment with an anxiolytic. The efficacy of buspirone hydrochloride tablets has been demonstrated in controlled clinical trials of outpatients whose diagnosis roughly corresponds to Generalized Anxiety Disorder (GAD). Many of the patients enrolled in these studies also had coexisting depressive symptoms and buspirone hydrochloride tablets relieved anxiety in the presence of these coexisting depressive symptoms. The patients evaluated in these st…
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 075521
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| busPIRone HClbuspirone hydrochloride | Buspirone hydrochloride 10 mg/1 | TabletOral | Bryant Ranch Prepack | 71335-9758 |
| busPIRone HClbuspirone hydrochloride | Buspirone hydrochloride 7.5 mg/1 | TabletOral | Advagen Pharma Ltd | 72888-063 |
| busPIRone HClbuspirone hydrochloride | Buspirone hydrochloride 5 mg/1 | TabletOral | Advagen Pharma Ltd | 72888-062 |
| busPIRone HClbuspirone hydrochloride | Buspirone hydrochloride 10 mg/1 | TabletOral | Advagen Pharma Ltd | 72888-064 |
| busPIRone HClbuspirone hydrochloride | Buspirone hydrochloride 15 mg/1 | TabletOral | Advagen Pharma Ltd | 72888-065 |
| busPIRone HClbuspirone hydrochloride | Buspirone hydrochloride 7.5 mg/1 | TabletOral | Northwind Health Company, LLC | 82868-082 |